Skip to main content
Signal8
Launch Terminal
Mowry Anna profile photo

Anna Mowry

CIK: 0001856938

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nautilus Biotechnology, Inc. logo
NAUT

Nautilus Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Mar 2, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    160K shares-
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    May 29, 2025
    Purchase(P)
    Direct
    15K shares at avg. $0.77$11K
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Mar 3, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    160K shares-

1-3 of 3

About Mowry Anna

Mowry Anna (SEC CIK 0001856938) files insider reports with the SEC as CFO and Treasurer of Nautilus Biotechnology, Inc. (NAUT).

Signal8 holds 3 ownership filings by Mowry Anna, all Form 4s, filed between Mar 4, 2025 and Mar 4, 2026. Those filings report 3 transactions, from Mar 3, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mowry Anna's filings is in SEATTLE, WA.

Recent filings by Mowry Anna

  • Mar 2, 2026: Grant or award of NAUT derivative securities (Form 4, code A).
  • May 29, 2025: Open-market purchase of NAUT shares (Form 4, code P).
  • Mar 3, 2025: Grant or award of NAUT derivative securities (Form 4, code A).

Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)

How to read Form 4 transaction codes